heiBIB: Bozorgmehr, Farastuk

Bozorgmehr, Farastuk Dr. med.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (47)
deutsch (1)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Chouaid, Christos: The impact of KRAS mutational status on patient-reported outcomes in advanced non-small-cell lung cancer : a cross sectional study in France and Germany / Christos Chouaid, Andromachi Giannopoulou,Alexandra Starry, Björn Stollenwerk, and Farastuk Bozorgme… , 2025. - 12 S. : Illustrationen
In: Journal of medical economics, ISSN 1941-837X. 28(2025), 1, Seite 13-24
DOI: 10.1080/13696998.2024.2437324
Waterhouse, David M.: Patient-reported outcomes in CodeBreaK 200 : sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation / David M. Waterhouse, Sacha Rothschild, Christophe Dooms, Bertrand Mennecier, Farastuk Bozorgmehr, Ma… , October 2024. - 12 S.
In: Lung cancer, ISSN 1872-8332. 196(2024) vom: Okt., Artikel-ID 107921, Seite [1]-12
DOI: 10.1016/j.lungcan.2024.107921
Budczies, Jan: KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma / Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Raj… , 12 June 2024. - 10 S. : Illustrationen
In: British journal of cancer, ISSN 1532-1827. 131(2024), 3, Seite 524-533
DOI: 10.1038/s41416-024-02746-z
Heidt, Christian: Delta-radiomics features of ADC maps as early predictors of treatment response in lung cancer / Christian M. Heidt, Jonas R. Bohn, Róbert Stollmayer, Oyunbileg von Stackelberg, Stephan Rheinheimer… , 26 August 2024. - 11 S. : Illustrationen
In: Insights into imaging, ISSN 1869-4101. 15(2024), Artikel-ID 218, Seite 1-11
DOI: 10.1186/s13244-024-01787-5
Bozorgmehr, Farastuk: Correction : Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 10 August 2023. - 1 S.
In: BMC cancer, ISSN 1471-2407. 23(2023), 1 vom: Aug., Artikel-ID 740, Seite 1
DOI: 10.1186/s12885-023-11270-x
Fink, Christoph Andreas: Comorbidity in limited disease small-cell lung cancer : age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy / Christoph A. Fink, Fabian Weykamp, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Kri… , 24 July 2023. - 7 S. : Illustrationen
In: Clinical and translational radiation oncology, ISSN 2405-6308. 42(2023) vom: Sept., Artikel-ID 100665, Seite 1-7
DOI: 10.1016/j.ctro.2023.100665
Blasi, Miriam: Pembrolizumab alone or with chemotherapy for 70+ year-old lung cancer patients : a retrospective study / Miriam Blasi, Jonas Kuon, Rajiv Shah, Farastuk Bozorgmehr, Florian Eichhorn, Stephan Liersch, Albrec… , November 2023. - 9 S.
In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 7 vom: Nov., Seite e282-e290
DOI: 10.1016/j.cllc.2023.06.010
Bozorgmehr, Farastuk: Immune checkpoint inhibitors in non-small cell lung cancer - when should we dare to stop treatment? / Farastuk Bozorgmehr, Annette Müller, Justyna Rawluk, Maria Sianidou, Inn Chung, Cornelia Kropf-Sanch… , October 2023. - 9 S. : Illustrationen
In: Lung cancer, ISSN 1872-8332. 184(2023) vom: Okt., Artikel-ID 107340, Seite 1-9
DOI: 10.1016/j.lungcan.2023.107340
Krämer, Anna Sabrina: Upfront and repeated stereotactic radiosurgery in patients with brain metastases from NSCLC / Anna S. Krämer, Sebastian Adeberg, Dorothea Kronsteiner, Laila König, Fabian Schunn, Farastuk Bozorg… , 27 April 2023. - 9 S.
In: Clinical lung cancer, ISSN 1938-0690. 24(2023), 3 vom: Apr., Seite 269-277
DOI: 10.1016/j.cllc.2023.01.002
Eichkorn, Tanja: High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes / Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antoni… , 13 January 2023. - 14 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2023) vom: Jan., Artikel-ID 1035370, Seite 1-14
DOI: 10.3389/fonc.2022.1035370
Bozorgmehr, Farastuk: Protocol of the TREASURE study : Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease$da randomized, open-label, multicenter phase II trial / Farastuk Bozorgmehr, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisa… , 24 September 2022. - 9 S.
In: BMC cancer, ISSN 1471-2407. 22(2022), Artikel-ID 1011, Seite 1-9
DOI: 10.1186/s12885-022-10074-9
Christopoulos, Petros: The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions / Petros Christopoulos, Klaus Kluck, Martina Kirchner, Heike Lüders, Julia Roeper, Roger-Fei Falkenste… , 20 May 2022. - 13 S.
In: European journal of cancer, ISSN 1879-0852. 170(2022) vom: Juli, Seite 106-118
DOI: 10.1016/j.ejca.2022.04.020
Mountzios, Giannis: Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer / G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. … , 1 September 2021. - 10 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100254, Seite 1-10
DOI: 10.1016/j.esmoop.2021.100254
Christopoulos, Petros: Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping : study protocol of the ABP trial / Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, Inn Chung, Johannes Krisam, Marc A. Schnei… , 28 June 2021. - 10 S.
In: BMC cancer, ISSN 1471-2407. 21(2021), Artikel-ID 743, Seite 1-10
DOI: 10.1186/s12885-021-08460-w
Hohmann, Nicolas: Pharmacoenhancement of low crizotinib plasma concentrations in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer using the CYP3A inhibitor cobicistat / Nicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos, Gerd Mikus, Antje Blank, Jürgen Burhenne… , 2021. - 5 S.
In: Clinical and translational science, ISSN 1752-8062. 14(2021), 2, Seite 487-491
DOI: 10.1111/cts.12921
El-Shafie, Rami: Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer / R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allg… , 2 June 2021. - 10 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 3, Artikel-ID 100161, Seite 1-10
DOI: 10.1016/j.esmoop.2021.100161
Daniello, Lea: Therapeutic and prognostic implications of immune-related adverse events in advanced non-small-cell lung cancer / Lea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, Jonas Kuon, Daniel Kazdal, Hannah Schindler, Raj… , 29 June 2021. - 14 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 29. Juni, Artikel-ID 703893, Seite 1-14
DOI: 10.3389/fonc.2021.703893
Fisch, David: Comprehensive dissection of treatment patterns and outcome for patients with metastatic large-cell neuroendocrine lung carcinoma / David Fisch, Farastuk Bozorgmehr, Daniel Kazdal, Jonas Kuon, Laura V. Klotz, Rajiv Shah, Florian Eic… , 08 July 2021. - 12 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 8. Juli, Artikel-ID 673901, Seite 1-12
DOI: 10.3389/fonc.2021.673901
Magios, Nikolaus: Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer / Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J. … , March 24, 2021. - 13 S.
In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835921996509, Seite 1-13
DOI: 10.1177/1758835921996509
Bozorgmehr, Farastuk: De Novo versus secondary metastatic EGFR-mutated non-small-cell lung cancer / Farastuk Bozorgmehr, Daniel Kazdal, Inn Chung, Martina Kirchner, Nikolaus Magios, Mark Kriegsmann, M… , 09 April 2021. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021), Artikel-ID 640048, Seite 1-9
DOI: 10.3389/fonc.2021.640048
El Sayed, Mei: Feasibility and challenges for sequential treatments in ALK-rearranged non-small-cell lung cancer / Mei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, Anna-Lena Volckmar, Holger Sültmann, Jürgen R. Fisc… , 20 April 2021. - 8 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: Apr., Artikel-ID 670483, Seite 1-8
DOI: 10.3389/fonc.2021.670483
Christopoulos, Petros: Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing / P. Christopoulos, M. Kirchner, J. Roeper, F. Saalfeld, M. Janning, F. Bozorgmehr, N. Magios, D. Kazd… , 22 August 2020. - 8 S.
In: Lung cancer, ISSN 1872-8332. 148(2020), Seite 105-112
DOI: 10.1016/j.lungcan.2020.08.007
Eichkorn, Tanja: Consolidation immunotherapy after platinum-based chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer : cross-sectional study of eligibility and administration rates / Tanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, Lisa A. Dinges, Andreas Kudak, Nina Bougatf,… , 01 December 2020. - 9 S.
In: Frontiers in oncology, ISSN 2234-943X. 10(2020) Artikel-Nummer 586449, 9 Seiten
DOI: 10.3389/fonc.2020.586449
Bozorgmehr, Farastuk: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy : study protocol of the TRADE-hypo trial / Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brück… , 26 August 2020. - 10 S.
In: BMC cancer, ISSN 1471-2407. 20(2020) Artikel-Nummer 806, 9 Seiten
DOI: 10.1186/s12885-020-07264-8
Janke, Florian: Novel liquid biomarker panels for a very early response capturing of NSCLC therapies in advanced stages / Florian Janke, Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus P. Heussel, Gudula Heussel,… , 12 April 2020. - 18 S.
In: Cancers, ISSN 2072-6694. 12(2020,4) Artikel-Nummer 954, 18 Seiten
DOI: 10.3390/cancers12040954
Rheinheimer, Stephan: Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors / Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke… , 23 April 2020. - 13 S.
In: Cancers, ISSN 2072-6694. 12(2020), 4, Artikel-ID 1046, Seite 1-13
DOI: 10.3390/cancers12041046
Kuon, Jonas: Durvalumab in frail and elderly patients with stage four non-small cell lung cancer : study protocol of the randomized phase II DURATION trial / Jonas Kuon, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Albrecht Stenzinger, Miriam Blasi… , 22 April 2020. - 12 S.
In: Trials, ISSN 1468-6694. 21(2020) Artikel-Nummer 352, 12 Seiten
DOI: 10.1186/s13063-020-04280-8
Eiff, Damian von: Paclitaxel for treatment of advanced small cell lung cancer (SCLC) : a retrospective study of 185 patients / Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, T… , [2020]. - 12 S.
In: Journal of thoracic disease, ISSN 2077-6624. 12(2020), 3, Seite 782-793
DOI: 10.21037/jtd.2019.12.74
Bozorgmehr, Farastuk: Fostering efficacy of anti-PD-1-treatment : Nivolumab plus radiotherapy in advanced non-small cell lung cancer : study protocol of the FORCE trial / Farastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Jonas Kuon, Martin Maenz… , 08 November 2019. - 11 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 1074, 11 Seiten
DOI: 10.1186/s12885-019-6205-0
Richtig, Georg: Awareness of predatory journals and open access among medical oncologists : results of an online survey / Georg Richtig, Erika Richtig, Alexandra Böhm, Christoph Oing, Farastuk Bozorgmehr, Stephan Kruger, B… , November 27, 2019. - 8 S.
In: ESMO open, ISSN 2059-7029. 4(2019) Artikel-Nummer e000580, 8 Seiten
DOI: 10.1136/esmoopen-2019-000580
Schlampp, Ingmar: Re-irradiation in locally recurrent lung cancer patients / Ingmar Schlampp, Juliane Rieber, Sebastian Adeberg, Farastuk Bozorgmehr, Claus Peter Heußel, Martin … , 1 April 2019. - 9 S.
In: Strahlentherapie und Onkologie, ISSN 1439-099X. 195(2019), 8, Seite 725-733
DOI: 10.1007/s00066-019-01457-2
Christopoulos, Petros: Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma / P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penz… , [1 January 2019]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 144(2019), 1, Seite 190-199
DOI: 10.1002/ijc.31893
Bernhardt, Denise: Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy / Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros … , 30 November 2018. - 7 S.
In: Cancer management and research, ISSN 1179-1322. 10(2018), Seite 6563-6569
DOI: 10.2147/CMAR.S180990
Christopoulos, Petros: Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance / Petros Christopoulos, Marc A. Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jen… , [May 2018]. - 8 S. : Illustrationen
In: Lung cancer, ISSN 1872-8332. 119(2018), Seite 48-55
DOI: 10.1016/j.lungcan.2018.03.002
Christopoulos, Petros: EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer / Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Rista… , [15 June 2018]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 142(2018), 12, Seite 2589-2598
DOI: 10.1002/ijc.31275
Christopoulos, Petros: Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features / Petros Christopoulos, Inn Chung, Farastuk Bozorgmehr, Thomas Muley, Michael Meister, Sonja Kobinger,… , [December 2018]. - 4 S. : Illustrationen
In: Histopathology, ISSN 1365-2559. 73(2018), 6, Seite 1040-1043
DOI: 10.1111/his.13724
Bernhardt, Denise: Generation of a new disease-specific prognostic score for patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy (BMS-score) and validation of two other indices / Denise Bernhardt, Laila König, Sophie Aufderstrasse, Johannes Krisam, Juliane Hoerner-Rieber, Sebast… , 2018. - 6 S.
In: Clinical lung cancer, ISSN 1938-0690. 19(2018), 4, Seite 340-345
DOI: 10.1016/j.cllc.2017.12.004
Bernhardt, Denise: Outcome and prognostic factors in single brain metastases from small-cell lung cancer / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hörner-Rieber, Lai… , 2018. - 9 S.
In: Strahlentherapie und Onkologie, ISSN 1439-099X. 194(2018), 2, Seite 98-106
DOI: 10.1007/s00066-017-1228-4
Bernhardt, Denise: Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hoerner-Rieber, La… , 30 May 2017. - 8 S.
In: Journal of neuro-oncology, ISSN 1573-7373. 134(2017), 1, Seite 205-212
DOI: 10.1007/s11060-017-2510-0
Leichsenring, Jonas: Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma / Jonas Leichsenring, Anna-Lena Volckmar, Nikolaus Magios, Cristiano Manuel Morais de Oliveira, Roland… , 2017. - 7 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 56(2017), 3, Seite 214-220
DOI: 10.1002/gcc.22427
Bernhardt, Denise: Nine-year experience : prophylactic cranial irradiation in extensive disease small-cell lung cancer / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hoerner-Rieber, Mi… , 2017. - 5 S.
In: Clinical lung cancer, ISSN 1938-0690. 18(2017), 4, Seite e267-e271
DOI: 10.1016/j.cllc.2016.11.012
Bernhardt, Denise: Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation / Denise Bernhardt, Farastuk Bozorgmehr, Sebastian Adeberg, Nils Opfermann, Damian von Eiff, Juliane R… , 13 September 2016. - 6 S.
In: Lung cancer, ISSN 1872-8332. 101(2016), Seite 76-81
DOI: 10.1016/j.lungcan.2016.09.010
Volckmar, Anna-Lena: Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient : a case report / Anna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, Clemens Lier, Carlota Porcel, Martina Kirchn… , 18 November 2016. - 6 S.
In: Diagnostic pathology, ISSN 1746-1596. 11(2016), Artikel-ID 133, Seite 1-6
DOI: 10.1186/s13000-016-0581-4
Volckmar, Anna-Lena: Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient : a case report / Anna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, Clemens Lier, Carlota Porcel, Martina Kirchn… . -
London: BioMed Central, 18 November 2016. - 1 Online-Ressource (6 Seiten)
DOI: 10.1186/s13000-016-0581-4
Mokry, Theresa: Retrospective study in 23 patients of the self-expanding Sinus-XL Stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer / Theresa Mokry, Nadine Bellemann, Christof M. Sommer, Claus P. Heussel, Farastuk Bozorgmehr, Daniel G… , 28 January 2015. - 9 S.
In: Journal of vascular and interventional radiology, ISSN 1535-7732. 26(2015), 3, Seite 357-365
DOI: 10.1016/j.jvir.2014.11.019
Flechsig, Paul: Invasive lung cancer staging : influence of CT-guided core needle biopsy on onset of pleural carcinomatosis / Paul Flechsig, Josef Kunz, Claus-Peter Heussel, Farastuk Bozorgmehr, Philipp Schnabel, Hendrik Diene… , 2015. - 6 S.
In: Clinical imaging, ISSN 1873-4499. 39(2015), 1, Seite 56-61
DOI: 10.1016/j.clinimag.2014.10.005
Schlotterer, Andrea: Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans / Andreas Schlotterer, Andreas Hamann, Georgi Kukudov, Youssef Ibrahim, Britta Heckmann, Farastuk Bozo… , 18 May 2010. - 13 S.
In: Aging cell, ISSN 1474-9726. 9(2010), 3 vom: Juni, Seite 420-432
DOI: 10.1111/j.1474-9726.2010.00572.x
Bozorgmehr, Farastuk: Einfluss der Multidrug resistance 1-Gentransfers auf die Langzeithämatopoese in nicht-humanen Primaten / vorgelegt von Farastuk Bozorgmehr, 2009. - VI, 101 S. : Ill., graph. Darst.

IDs

GND:

141921811

Links

Bozorgmehr, Farastuk in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design